Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT

Bone Marrow Transplant. 2014 Nov;49(11):1448-9. doi: 10.1038/bmt.2014.162. Epub 2014 Jul 28.

Authors

M Jung¹, V N Ranpura², C E Dunbar¹, J F Tisdale³, C D Fitzhugh³, M M Hsieh³

Affiliations

¹ Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
² Department of Hematology and Oncology, Washington Hospital Center, Washington, DC, USA.
³ Molecular and Clinical Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Intramural

MeSH terms

Adult
Allografts
Anemia, Sickle Cell / therapy*
Angioedema / chemically induced*
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / adverse effects*
Female
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Sirolimus / administration & dosage
Sirolimus / adverse effects*

Substances

Angiotensin-Converting Enzyme Inhibitors
Sirolimus

Grants and funding

ZIA HL006007-06/Intramural NIH HHS/United States